Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ALEMTUZUMAB Cause Incorrect product administration duration? 12 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Incorrect product administration duration have been filed in association with ALEMTUZUMAB (Campath). This represents 0.1% of all adverse event reports for ALEMTUZUMAB.

12
Reports of Incorrect product administration duration with ALEMTUZUMAB
0.1%
of all ALEMTUZUMAB reports
0
Deaths
0
Hospitalizations

How Dangerous Is Incorrect product administration duration From ALEMTUZUMAB?

Of the 12 reports.

Is Incorrect product administration duration Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does ALEMTUZUMAB Cause?

Headache (1,808) Fatigue (1,744) Pyrexia (1,441) Off label use (1,259) Rash (1,094) Nausea (1,053) Dyspnoea (855) Lymphocyte count decreased (852) Asthenia (841) Multiple sclerosis relapse (836)

What Other Drugs Cause Incorrect product administration duration?

ETONOGESTREL (3,974) POLYETHYLENE GLYCOL 3350 (2,129) NIRMATRELVIR\RITONAVIR (744) DOCOSANOL (634) LANSOPRAZOLE (564) LOPERAMIDE (543) NAPROXEN (499) INSULIN LISPRO (479) DICLOFENAC (362) OMEPRAZOLE (302)

Which ALEMTUZUMAB Alternatives Have Lower Incorrect product administration duration Risk?

ALEMTUZUMAB vs ALENDRONATE ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL ALEMTUZUMAB vs ALENDRONIC ACID ALEMTUZUMAB vs ALEVE ALEMTUZUMAB vs ALEVE CAPLET

Related Pages

ALEMTUZUMAB Full Profile All Incorrect product administration duration Reports All Drugs Causing Incorrect product administration duration ALEMTUZUMAB Demographics